| Literature DB >> 28903179 |
Thiago Levi Silva Oliveira1, Sandra Ribeiro de Morais2, Stone de Sá3, Matheus Gabriel de Oliveira4, Iziara Ferreira Florentino5, Dayane Moreira da Silva6, Verônica Vale Carvalho7, Vinícius Barreto da Silva8, Boniek Gontijo Vaz9, José Ricardo Sabino10, Elson Alves Costa11, José Realino de Paula12.
Abstract
Hydrocotyle umbellata Linn. (Araliaceae) is specie used in the treatment of inflammatory diseases. Crude extract (E-HU) was prepared from H. umbellata subterraneous parts and fractionated by liquid-liquid partition, resulting hexane fraction (HF-HU), dichloromethane fraction (DF-HU), ethyl acetate fraction (EAF-HU) and aqueous fraction (AF-HU). The hibalactone (HU-1) was isolated from the DF-HU and its structure was elucidated by 1H NMR and 13C NMR Spectroscopy, mass spectrometry and crystallographic x-ray analysis. The formalin-induced nociception was used to evaluate antinociceptive activity; carrageenan-induced edema and pleurisy tests to evaluate anti-inflammatory activity and light-dark box to evaluate anxiolytic-like activity in mice. The acute oral treatments with E-HU (1000mg/kg), DF-HU (150mg/kg), EAF-HU (400mg/kg) and HU-1 (33mg/kg) decreased the licking time in both phases of the formalin test. In the carrageenan-induced inflammation models, the treatment with the same doses of E-HU, DF-HU, EAF-HU and HU-1 reduced the paw edema formation and leukocytes account into pleural cavity. In silico findings suggest that hibalactone present anti-inflammatory activity by interacting with the enzymes 5-lipoxygenase and cyclooxygenase-2. In the light dark box, the treatments with DF-HU, EAF-HU and HU-1 revealed an anxiolytic like effect. Thus, the E-HU and fractions of H. umbellata showed antinociceptive, anti-inflammatory and anxiolytic like activities, as also hibalactone, a possible phytoconstituent responsible for the biological effects of this specie.Entities:
Keywords: Anti-inflammatory; Antinociceptive; Anxiolytic-like; Hibalactone; Hydrocotyle umbellata L.; Medicinal plants
Mesh:
Substances:
Year: 2017 PMID: 28903179 DOI: 10.1016/j.biopha.2017.08.140
Source DB: PubMed Journal: Biomed Pharmacother ISSN: 0753-3322 Impact factor: 6.529